Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CABA
Stock Latest News
Company Announcements
Cabaletta Bio’s RESET-MG Study: A Potential Game-Changer for Myasthenia Gravis Treatment
1d ago
CABA
Premium
Company Announcements
Cabaletta Bio’s RESET-Myositis Study: A Promising Step in Autoimmune Treatment
2d ago
CABA
Premium
Company Announcements
Cabaletta Bio’s RESET-MG Study: A Promising Step in Myasthenia Gravis Treatment
3d ago
CABA
Premium
Company Announcements
Cabaletta Bio’s RESET-Myositis Study: A Potential Game-Changer in Autoimmune Disease Treatment
4d ago
CABA
Premium
Company Announcements
Cabaletta Bio Announces $94 Million Public Offering
1M ago
8K
CABA
Premium
Ratings
Promising Clinical Data and Positive Trajectory Support Buy Rating for Cabaletta Bio
1M ago
CABA
Premium
Ratings
Promising Clinical Data from Cabaletta Bio’s RESET Trial Supports Buy Rating
1M ago
CABA
Premium
Ratings
Promising Efficacy and Strategic Advancements: Douglas Tsao’s Buy Rating on Cabaletta Bio
1M ago
CABA
Premium
The Fly
Cabaletta presents ‘promising’ results across indications, says H.C. Wainwright
1M ago
CABA
Premium
Company Announcements
Cabaletta Bio Ends Sales Agreement with TD Securities
1M ago
8K
CABA
Premium
The Fly
Cabaletta Bio announces offering of common stock, warrants, no amount given
1M ago
CABA
Premium
The Fly
Cabaletta Bio reports data from the RESET trials evaluating rese-cel
1M ago
CABA
Premium
Company Announcements
Cabaletta Bio Stockholders Approve Key Proposals
1M ago
8K
CABA
Premium
Company Announcements
Cabaletta Bio Reprices Stock Options to Motivate Staff
2M ago
8K
CABA
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
ACAD
AFMD
Premium
Ratings
Cabaletta Bio: Hold Rating Amid Cash Constraints and Regulatory Challenges
2M ago
CABA
Premium
Ratings
Cabaletta Bio’s Strategic Advancements and Trial Successes Drive Buy Rating
2M ago
CABA
Premium
The Fly
Cabaletta Bio price target lowered to $13 from $17 at Citi
2M ago
CABA
Premium
Ratings
Cabaletta Bio’s Strong Financial Position and Strategic Clinical Progress Justify Buy Rating
2M ago
CABA
Premium
The Fly
Cabaletta Bio price target raised to $25 from $23 at Guggenheim
2M ago
CABA
Premium
Company Announcements
Cabaletta Bio Announces 2027 BLA Plans for Rese-cel
2M ago
8K
CABA
Premium
The Fly
Cabaletta Bio announces plans for anticipated 2027 rese-cel BLA submission
2M ago
CABA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
